Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Ann Diagn Pathol ; 48: 151560, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-621789


The coronavirus disease 2019 (COVID-19) pandemic has dramatically changed the world over the past weeks, with already 8,25 million infections and 445,000 deaths worldwide, leading to an unprecedented international global effort to contain the virus and prevent its spread. The emergence of novel respiratory viruses such as the SARS-CoV-2 creates dramatic challenges to the healthcare services, including surgical pathology laboratories, despite their extensive daily experience in dealing with biological and chemical hazards. Here, we cover important aspects on the knowledge on COVID-19 gathered during the first six months of the pandemic and address relevant issues on human biological sample handling in the Anatomic Pathology laboratory in the context of COVID-19 global threat. In addition, we detail our strategy to minimize the risk of contamination upon exposure to the different biological products received in the laboratory, which can be of general interest to other laboratories worldwide. Our approach has enabled a safe work environment for laboratory staff, while ensuring the maintenance of high quality standards of the work performed. In times of uncertainty and given the lack of specific guidelines directed at Anatomic Pathology services to better deal with the global COVID-19 public-health emergency, it is essential to share with the community rigorous methodologies that will enable us to better cope with probable novel waves of COVID-19 infection and other viruses that will possibly arise in the near future.

Coronavirus Infections , Infection Control/methods , Laboratories, Hospital/standards , Pandemics , Pathology, Surgical/methods , Pneumonia, Viral , Specimen Handling/methods , Betacoronavirus , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Humans , Infection Control/standards , Pandemics/prevention & control , Pathology Department, Hospital/standards , Pathology, Surgical/standards , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Portugal , Specimen Handling/standards
JACC Cardiovasc Interv ; 13(16): 1951-1957, 2020 08 24.
Article in English | MEDLINE | ID: covidwho-609703


As the world slowly starts to recover from the coronavirus disease-2019 pandemic, health care systems are now thinking about resuming elective cardiovascular procedures, including procedures in cardiac catheterization laboratories. Rebooting catheterization laboratories will be an arduous process, in part because of limited health care resources, new processes, and fears stemming from the coronavirus disease-2019 pandemic. The authors propose a detailed phased-in approach that considers clinical, patient-centered, and operational strategies to safely and effectively reboot catheterization laboratory programs during these unprecedented times. This model balances the delivery of essential cardiovascular care with reduced exposure and preservation of resources. The guiding principles detailed in this review can be used by catheterization laboratory programs when restarting elective interventional procedures.

Betacoronavirus , Cardiac Catheterization/standards , Cardiac Surgical Procedures/standards , Coronavirus Infections/complications , Delivery of Health Care/standards , Laboratories, Hospital/standards , Pneumonia, Viral/complications , Practice Guidelines as Topic , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Elective Surgical Procedures/standards , Humans , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology